Skip to main content

Kindred Biosciences, Inc.

KINDelisted Aug 27, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0001561743

Kindred Biosciences, Inc. was delisted on Aug 27, 2021; its insiders filed their last Form 4 on Sep 13, 2021; 87 institutions reported holding it in 13F filings for Q2 2021, worth $311.0M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Kindred Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of KIN: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders10−1
Shares2.50K0−2.50K (−100.0%)
Value$11.0K$0−$11.0K (−100.0%)

New holders (0)

Institutions that held Kindred Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

None.

Sold out (1)

Institutions that held Kindred Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of KIN in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
CVA Family Office, LLC2,500$11.0K